671 related articles for article (PubMed ID: 25778500)
21. [Unmet needs in systemic lupus erythematosus].
Ichinose K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):396-407. PubMed ID: 29367524
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic Strategies of Neuropsychiatric Systemic Lupus Erythematosus].
Nakane S; Ichinose K; Kawakami A
Brain Nerve; 2021 May; 73(5):516-525. PubMed ID: 34006684
[TBL] [Abstract][Full Text] [Related]
23. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
24. Systemic lupus erythematosus: a review of the disease and treatment options.
Gurevitz SL; Snyder JA; Wessel EK; Frey J; Williamson BA
Consult Pharm; 2013 Feb; 28(2):110-21. PubMed ID: 23395811
[TBL] [Abstract][Full Text] [Related]
25. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.
Tselios K; Sheane BJ; Gladman DD; Urowitz MB
J Rheumatol; 2016 Jan; 43(1):54-65. PubMed ID: 26568591
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
[TBL] [Abstract][Full Text] [Related]
27. [Recent progress in neuropsychiatric systemic lupus erythematosus].
Tanaka Y
Brain Nerve; 2013 Nov; 65(11):1255-67. PubMed ID: 24200603
[TBL] [Abstract][Full Text] [Related]
28. [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].
Trujillo-Martín MM; Rúa-Figueroa Fernández de Larrinoa I; Ruíz-Irastorza G; Pego-Reigosa JM; Sabio Sánchez JM; Serrano-Aguilar P;
Med Clin (Barc); 2016 May; 146(9):413.e1-14. PubMed ID: 26975887
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic criteria for systemic lupus erythematosus: a critical review.
Yu C; Gershwin ME; Chang C
J Autoimmun; 2014; 48-49():10-3. PubMed ID: 24461385
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus.
Nagai Y; Yokogawa N; Shimada K; Sugii S
Rheumatol Int; 2019 Sep; 39(9):1567-1573. PubMed ID: 31309295
[TBL] [Abstract][Full Text] [Related]
31. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
Keeling SO; Alabdurubalnabi Z; Avina-Zubieta A; Barr S; Bergeron L; Bernatsky S; Bourre-Tessier J; Clarke A; Baril-Dionne A; Dutz J; Ensworth S; Fifi-Mah A; Fortin PR; Gladman DD; Haaland D; Hanly JG; Hiraki LT; Hussein S; Legault K; Levy D; Lim L; Matsos M; McDonald EG; Medina-Rosas J; Pardo Pardi J; Peschken C; Pineau C; Pope J; Rader T; Reynolds J; Silverman E; Tselios K; Suitner M; Urowitz M; Touma Z; Vinet E; Santesso N
J Rheumatol; 2018 Oct; 45(10):1426-1439. PubMed ID: 30173152
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
33. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.
Mosca M; Tani C; Aringer M; Bombardieri S; Boumpas D; Brey R; Cervera R; Doria A; Jayne D; Khamashta MA; Kuhn A; Gordon C; Petri M; Rekvig OP; Schneider M; Sherer Y; Shoenfeld Y; Smolen JS; Talarico R; Tincani A; van Vollenhoven RF; Ward MM; Werth VP; Carmona L
Ann Rheum Dis; 2010 Jul; 69(7):1269-74. PubMed ID: 19892750
[TBL] [Abstract][Full Text] [Related]
34. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.
Groot N; de Graeff N; Avcin T; Bader-Meunier B; Brogan P; Dolezalova P; Feldman B; Kone-Paut I; Lahdenne P; Marks SD; McCann L; Ozen S; Pilkington C; Ravelli A; Royen-Kerkhof AV; Uziel Y; Vastert B; Wulffraat N; Kamphuis S; Beresford MW
Ann Rheum Dis; 2017 Nov; 76(11):1788-1796. PubMed ID: 28630236
[TBL] [Abstract][Full Text] [Related]
35. Mobile health apps for systemic lupus erythematosus and lupus nephritis: a critical appraisal.
Ramasamy A; Dugyala P; Mohan C
Arthritis Res Ther; 2022 May; 24(1):110. PubMed ID: 35568874
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
37. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
38. Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.
Golan TD
Curr Rheumatol Rep; 2002 Feb; 4(1):18-24. PubMed ID: 11798978
[TBL] [Abstract][Full Text] [Related]
39. The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations.
Klumb EM; Scheinberg M; Souza VA; Xavier RM; Azevedo VF; McElwee E; Restrepo MR; Monticielo OA
Lupus; 2021 Sep; 30(10):1684-1695. PubMed ID: 34255586
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients.
Hax V; Moro ALD; Piovesan RR; Goldani LZ; Xavier RM; Monticielo OA
Adv Rheumatol; 2018 Jul; 58(1):12. PubMed ID: 30657064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
